Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Executive Vice President | February 18, 2009 | February 20, 2009 |
| FREDS INCFRED · Entity 158922 | Director | March 07, 2017 | March 13, 2017 |
| OneWater Marine Inc.ONEW · Entity 2215 | Director | October 01, 2025 | October 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date February 18, 2009 · Filed February 20, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,132.0986 |
Reported balance
After 2009-02-18 transaction · row 1
1 source rowRow 1 · 2009-02-18 · Grant · Acquired 20,549 · Balance 23,132.0986 F1: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 188,353.2454 |
Reported balance
Holding disclosure · report date 2009-02-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 188,353.2454 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 104,650 |
Reported balance
Holding disclosure · report date 2009-02-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 104,650 |
| Esop Preference StockSEC Table I · non-derivative | IndirectBy Esop | 309 |
Reported balance
Holding disclosure · report date 2009-02-18 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 309 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan.
FREDS INC
Report date March 07, 2017 · Filed March 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 8,091 |
Reported balance
Holding disclosure · report date 2017-03-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 8,091 F1: Granted shares of restricted stock which vest upon retirement from the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Granted shares of restricted stock which vest upon retirement from the Board of Directors.
OneWater Marine Inc.
Report date October 01, 2025 · Filed October 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, par value $0.01SEC Table I · non-derivative | Direct | 33,928 |
Reported balance
After 2025-10-01 transaction · row 1
1 source rowRow 1 · 2025-10-01 · Grant · Acquired 7,892 · Balance 33,928 F1: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2026, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2026, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Allergan plc
Report date May 08, 2020 · Filed May 11, 2020
Section 16 reporting ended · disclosed 2020-05-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value $0.0001SEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-05-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-05-08 · Disposition to issuer · Disposed 18,615 · Balance 0 F1: Reflects the disposition of ordinary shares ("Allergan Shares") of Allergan plc ("Allergan") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. ("AbbVie"), Venice Subsidiary, LLC ("Acquirer Sub") and Allergan (the "Transaction Agreement"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the "Scheme"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of ordinary shares ("Allergan Shares") of Allergan plc ("Allergan") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. ("AbbVie"), Venice Subsidiary, LLC ("Acquirer Sub") and Allergan (the "Transaction Agreement"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the "Scheme"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2025 Filed Oct 6, 2025 16:08 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 7,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001772921-25-000070 · wk-form4_1759781276.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,928 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2026, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 16:18 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 5,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001772921-24-000086 · wk-form4_1727986680.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,036 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2025, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 17:13 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 4,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001772921-23-000058 · wk-form4_1696367580.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,808 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2024, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:06 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-009024 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,928 F1 · kind: Award of restricted stock units, subject to shareholder approval of an amendment to the OneWater Marine Inc. 2020 Omnibus Incentive Plan under which the restricted stock units were granted. OneWater Marine Inc's stockholders approved the amendment on February 23, 2023. The award vests on October 1, 2023, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:57 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 2,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-036193 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,267 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on October 1, 2023, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:01 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 2,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-033549 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,397 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on September 30, 2022, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| October 01, 2021 Filed Feb 24, 2022 21:01 UTC Amendment | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 1,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-006683 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,776 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on September 30, 2022, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. F2 · shares: The Form 4 originally filed on October 4, 2021 inadvertently reported the incorrect number of shares of Class A common stock, par value $0.01, acquired and beneficially owned by the Reporting Person pursuant to the award of restricted stock units. This amendment is being filed to correct the originally reported amount of Class A common stock acquired and beneficially owned by the Reporting Person pursuant to the award of restricted stock units. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:31 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 3,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-022503 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,910 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on September 30, 2021, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| May 08, 2020 Filed May 11, 2020 21:54 UTC | Allergan plc AGN · Entity 149298 | Disposition to issuerOrdinary Shares, par value $0.0001 | 18,615 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012759 · doc4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Reflects the disposition of ordinary shares ("Allergan Shares") of Allergan plc ("Allergan") as contemplated by the Transaction Agreement dated as of June 25, 2019 among AbbVie Inc. ("AbbVie"), Venice Subsidiary, LLC ("Acquirer Sub") and Allergan (the "Transaction Agreement"), pursuant to which Acquirer Sub acquired Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act of 2014 and the capital reduction under Sections 84 and 85 of the Act (the "Scheme"). In accordance with the terms of the Transaction Agreement, at the effective time of the Scheme, each Allergan Share was converted into $120.30 in cash and 0.8660 of a newly issued share of AbbVie common stock, par value $0.01 per share. Read SEC document |
| May 01, 2020 Filed May 4, 2020 20:56 UTC | Allergan plc AGN · Entity 149298 | Tax withholdingOrdinary Shares, par value $0.0001 | 991 | $189.74 | $188,032.34 |
DisclosureSEC source: 0001179110-20-005445 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,615 Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:45 UTC | OneWater Marine Inc. ONEW · Entity 2215 | GrantClass A common stock, par value $0.01 | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-004873 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · kind: Award of restricted stock units pursuant to the OneWater Marine Inc. 2020 Omnibus Incentive Plan. The award vests on February 7, 2021, subject to the recipient's continued service as a director of OneWater Marine Inc. through such vesting date. Read SEC document |
| May 02, 2019 Filed May 2, 2019 16:37 UTC | Allergan plc AGN · Entity 149298 | GrantOrdinary Shares, par value $0.0001 | 2,064 | $145.33 | $299,961.12 |
DisclosureSEC source: 0001179110-19-005401 · edgar.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,606 F2 · shares: These restricted stock units shall vest 100% on the earlier of (i) the day before the 2020 Annual General Meeting of Shareholders and (ii) May 1, 2020. F1 · balance_after: Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| April 30, 2019 Filed May 2, 2019 16:37 UTC | Allergan plc AGN · Entity 149298 | Tax withholdingOrdinary Shares, par value $0.0001 | 953 | $147.00 | $140,091.00 |
DisclosureSEC source: 0001179110-19-005401 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,542 F1 · balance_after: Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 02, 2018 Filed May 4, 2018 18:16 UTC | Allergan plc AGN · Entity 149298 | GrantOrdinary Shares, par value $0.0001 | 1,985 | $151.07 | $299,873.95 |
DisclosureSEC source: 0001179110-18-006351 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,495 F1 · shares: These restricted stock units shall vest 100% on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019. F2 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 01, 2018 Filed May 3, 2018 09:57 UTC | Allergan plc AGN · Entity 149298 | Tax withholdingOrdinary Shares, par value $0.0001 | 588 | $152.94 | $89,928.72 |
DisclosureSEC source: 0001179110-18-006110 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,510 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| December 07, 2017 Filed Dec 7, 2017 17:21 UTC | Allergan plc AGN · Entity 149298 | PurchaseOrdinary Shares, par value $0.0001 | 3,030 | $164.77 | $499,253.10 |
DisclosureSEC source: 0001179110-17-015076 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,098 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 04, 2017 Filed May 5, 2017 18:23 UTC | Allergan plc AGN · Entity 149298 | GrantOrdinary Shares, par value $0.0001 | 1,223 | $245.25 | $299,940.75 |
DisclosureSEC source: 0001179110-17-006727 · edgar.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,068 F2 · shares: These restricted stock units shall vest 100% on the earlier of (i) the day before the 2018 Annual General Meeting of Shareholders or (ii) May 4, 2018. F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| May 03, 2017 Filed May 5, 2017 18:23 UTC | Allergan plc AGN · Entity 149298 | Tax withholdingOrdinary Shares, par value $0.0001 | 668 | $243.76 | $162,831.68 |
DisclosureSEC source: 0001179110-17-006727 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,845 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| August 17, 2016 Filed Jan 27, 2017 17:29 UTC | Allergan plc AGN · Entity 149298 | GiftOrdinary Shares, par value $0.0001 | 766 | $253.30 | $194,027.80 |
DisclosureSEC source: 0001179110-17-001309 · edgar.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,513 F1 · shares: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 20,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004353 · form4.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,132.0986 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · derivative · entry 12 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2012-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option becomes exercisable in three annual installments, commencing 1/5/2006. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 50,000 | $0.00 Strike: $19.28 | $0.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · derivative · entry 11 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2010-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal installments, commencing 1/3/2002 Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · derivative · entry 10 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2011-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/8/2005. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 42,500 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · derivative · entry 9 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,500 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/2/2004. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,000 | $0.00 Strike: $12.56 | $0.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · derivative · entry 8 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2013-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/9/2005. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 372,500 | $42.35 | $15,776,567.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 6 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583.0986 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 100,000 | $22.45 | $2,244,500.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 5 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,083.0986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 50,000 | $19.28 | $964,065.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 4 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,083.0986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 100,000 | $17.67 | $1,766,750.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 3 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,083.0986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 42,500 | $14.96 | $635,906.25 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,083.0986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| May 23, 2008 Filed May 28, 2008 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,000 | $12.56 | $1,005,000.00 |
DisclosureSEC source: 0000064803-08-000064 · doc.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,583.0986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 144,144 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000040 · doc.xml · derivative · entry 15 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,144 Underlying: Common Stock · 144,144 shares Expires 2015-04-01 F7 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 30,362 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000040 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,650 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 04/01/2011 and 50% on 04/01/2013. Read SEC document |
| February 12, 2008 Filed Feb 14, 2008 21:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 14,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000021 · doc.xml · nonDerivative · entry 3 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,648.9257 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000148 · doc.xml · derivative · entry 17 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2009-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 3/10/2001. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 47,512 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0000064803-07-000148 · doc.xml · derivative · entry 16 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 47,512 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 1/2/2003. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 77,512 | $37.61 | $2,915,412.35 |
DisclosureSEC source: 0000064803-07-000148 · doc.xml · nonDerivative · entry 3 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,323 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 30,000 | $25.00 | $750,000.00 |
DisclosureSEC source: 0000064803-07-000148 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 30, 2007 Filed Sep 4, 2007 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 47,512 | $14.96 | $710,898.30 |
DisclosureSEC source: 0000064803-07-000148 · doc.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 17,400 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000064803-07-000114 · doc.xml · derivative · entry 17 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,400 shares Expires 2008-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commmencing 02/27/01. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 17,400 | $37.50 | $652,500.00 |
DisclosureSEC source: 0000064803-07-000114 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,323 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| June 11, 2007 Filed Jun 12, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 17,400 | $18.35 | $319,249.98 |
DisclosureSEC source: 0000064803-07-000114 · doc.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 136,089 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000080 · doc.xml · derivative · entry 16 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,089 Underlying: Common Stock · 136,089 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 13,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000080 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,388 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:20 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000090 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,288 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| February 12, 2007 Filed Feb 20, 2007 18:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 9,436 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000033 · doc.xml · nonDerivative · entry 3 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,110 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 161,359 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001194405-06-000009 · doc.xml · derivative · entry 3 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,359 Underlying: Common Stock · 161,359 shares Expires 2013-04-03 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/3/07 Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 16,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000009 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,214 Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 14,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000009 · doc.xml · nonDerivative · entry 1 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,566 Read SEC document |
| March 14, 2006 Filed Mar 16, 2006 21:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 25 | $30.57 | $764.25 |
DisclosureSEC source: 0001194405-06-000008 · doc.xml · nonDerivative · entry 2 BODINE CHRIS W · CIK 0001194405 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,051 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.